Pacific Shuanglin Bio-pharmacy Co., LTD

SZSE:000403 Stok Raporu

Piyasa değeri: CN¥18.1b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Pacific Shuanglin Bio-pharmacy Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Pacific Shuanglin Bio-pharmacy is forecast to grow earnings and revenue by 13.4% and 15% per annum respectively. EPS is expected to grow by 13.2% per annum. Return on equity is forecast to be 10.9% in 3 years.

Anahtar bilgiler

13.4%

Kazanç büyüme oranı

13.2%

EPS büyüme oranı

Biotechs kazanç büyümesi38.5%
Gelir büyüme oranı15.0%
Gelecekteki özkaynak getirisi10.9%
Analist kapsamı

Low

Son güncelleme24 Sep 2024

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Pacific Shuanglin Bio-pharmacy Co., LTD's (SZSE:000403) Shares May Have Run Too Fast Too Soon

Aug 16
Pacific Shuanglin Bio-pharmacy Co., LTD's (SZSE:000403) Shares May Have Run Too Fast Too Soon

We Think Pacific Shuanglin Bio-pharmacy (SZSE:000403) Can Stay On Top Of Its Debt

Jul 22
We Think Pacific Shuanglin Bio-pharmacy (SZSE:000403) Can Stay On Top Of Its Debt

Is Now The Time To Put Pacific Shuanglin Bio-pharmacy (SZSE:000403) On Your Watchlist?

May 24
Is Now The Time To Put Pacific Shuanglin Bio-pharmacy (SZSE:000403) On Your Watchlist?

Kazanç ve Gelir Büyüme Tahminleri

SZSE:000403 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/20263,9941,075N/A1,0285
12/31/20253,497923N/A8595
12/31/20243,000779N/A5795
6/30/20242,756796286635N/A
3/31/20242,504678134521N/A
12/31/20232,329612302679N/A
9/30/20232,28756438473N/A
6/30/20232,12350911452N/A
3/31/20232,166538142553N/A
1/1/20232,405587146524N/A
9/30/20222,123437155477N/A
6/30/20222,172436246532N/A
3/31/20222,187440118459N/A
1/1/20221,97239182408N/A
9/30/20211,730386219465N/A
6/30/20211,413299198400N/A
3/31/20211,12421786174N/A
1/1/20211,050186155195N/A
9/30/2020937137-4123N/A
6/30/2020941146-1047N/A
3/31/2020949161213255N/A
1/1/2020916160150191N/A
9/30/2019867127131166N/A
6/30/201983591115152N/A
3/31/20198197676111N/A
1/1/20198608082117N/A
9/30/2018805603266N/A
6/30/201879144718N/A
3/31/201877130N/A0N/A
12/31/201768522N/A-15N/A
9/30/201765234N/A-7N/A
6/30/201760052N/A-11N/A
3/31/201753052N/A1N/A
12/31/201656150N/A62N/A
9/30/201654568N/A40N/A
6/30/201652766N/A50N/A
3/31/201655481N/A69N/A
12/31/201550078N/A70N/A
9/30/201556870N/A119N/A
6/30/201558775N/A107N/A
3/31/201551332N/A99N/A
12/31/2014489123N/A77N/A
9/30/2014403105N/A78N/A
6/30/2014393118N/A114N/A
3/31/2014444149N/A83N/A
12/31/201347870N/A91N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 000403's forecast earnings growth (13.4% per year) is above the savings rate (2.9%).

Kazançlar ve Piyasa: 000403's earnings (13.4% per year) are forecast to grow slower than the CN market (23.2% per year).

Yüksek Büyüme Kazançları: 000403's earnings are forecast to grow, but not significantly.

Gelir ve Pazar: 000403's revenue (15% per year) is forecast to grow faster than the CN market (13.2% per year).

Yüksek Büyüme Geliri: 000403's revenue (15% per year) is forecast to grow slower than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 000403's Return on Equity is forecast to be low in 3 years time (10.9%).

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y